Impact of breast cancer therapies goes beyond just health

That is the finding from Daysal et al. (2025). We reproduce the results from an RCT showing the life-saving benefits of radiotherapy. We show radiation therapy also has economic returns: Ten years after diagnosis, treatment increases employment by 37 percent and earnings by 45 percent. Previous work has documented a substantial employment drop after a…

Read More

Jim Gallic shows off Wondr Health

Jim Gallic is Chief Growth Officer at Wondr Health, a company specializing in creating the behavior change required for weight loss. He was a satisfied client who lost a ton of weight (see that before and after photo on the right!) and changed his eating habits completely using Wondr (no drugs involved!). Later in life…

Read More

Listen to the Latest ‘KFF Health News Minute’

Jan. 8 Zach Dyer reads the week’s news: Instead of extending extra Affordable Care Act subsidies that would keep monthly premiums more affordable, some Republicans are pushing health savings accounts. Plus, people seeking cheaper health insurance options outside the ACA marketplaces may find some, but they come with downsides.  Jan. 1 Katheryn Houghton reads the week’s news: AI voices can help patients who have had their…

Read More

Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria

That is the tile of my recent paper in the Journal of Medical Economics with co-authors Kyi-Sin Than, Sanjana Muthukrishnan, Jincy Paulose, Ver Bilano and Nicholas Kuypers. The abstract is below: ObjectiveParoxysmal nocturnal hemoglobinuria (PNH) is a rare and debilitating hematological disease with significant economic burden. Despite the availability of multiple therapies, there is a…

Read More